All In MedTech

FDA Clearance Tracker · P060040-S115

HeartMate II Left Ventricular Assist System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 23, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 23, 2025

Approved

Time to decision

81 days

Received Mar 3, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P060040-S115
Device name
HeartMate II Left Ventricular Assist System
Applicant location
Pleasanton, CA
Received
Mar 3, 2025
Decided
May 23, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P060040

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code DSQ

FDA's approval statement

As written in FDA's record.

Approval for an update of the HeartMate Touch Communication system, including the off-the-shelf iPad hardware, the iPad operating system, and HeartMate Touch application.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.